SIRT2 and SIRT3 expression correlates with redox imbalance and advanced clinical stage in patients with multiple myeloma-Reference-Cited by-同舟云学术

SIRT2 and SIRT3 expression correlates with redox imbalance and advanced clinical stage in patients with multiple myeloma

Published:2021-07 Issue: Volume:93 Page:42-49
ISSN:0009-9120
Container-title:Clinical Biochemistry
language:en
Short-container-title:Clinical Biochemistry

Author:

Allegra Alessandro^ORCID,Innao Vanessa^ORCID,Polito Francesca,Oteri Rosaria,Alibrandi Angela,Allegra Andrea Gaetano,Oteri Giacomo,Di Giorgio Rosa Maria,Musolino Caterina,Aguennouz M'hammed

Publisher

Elsevier BV

Subject

Clinical Biochemistry,General Medicine

Reference42 articles.

1. Trends in overall survival and costs of multiple myeloma 2000–2014;Fonseca;Leukemia.,2017

2. Novel investigational drugs active as single agents in multiple myeloma;D’Agostino;Expert. Opin. Investig. Drug.,2017

3. A phase 1, open-label study of LCAR-B38M, a chimeric antigen receptor T cell therapy directed against B cell maturation antigen, in patients with relapsed or refractory multiple myeloma;Zhao;J. Hematol. Oncol.,2018

4. Immunoproteasome-selective and non-selective inhibitors: A promising approach for the treatment of multiple myeloma;Ettari;Pharmacol. Ther.,2018

5. New orally active proteasome inhibitors in multiple myeloma;Allegra;Leuk. Res.,2014

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Gene expression patterns of Sirtuin family members (SIRT1 TO SIRT7): Insights into pathogenesis and prognostic of Myelodysplastic neoplasm;Gene;2024-07

2. Effect of Diet and Oxidative Stress in the Pathogenesis of Lymphoproliferative Disorders;Antioxidants;2023-08-26

3. Multiple myeloma, a quintessential malignant disease of aging: a geroscience perspective on pathogenesis and treatment;GeroScience;2022-12-12

4. Role of Sirtuins in the Pathobiology of Onco-Hematological Diseases: A PROSPERO-Registered Study and In Silico Analysis;Cancers;2022-09-23

5. Targeting Redox Regulation as a Therapeutic Opportunity against Acute Leukemia: Pro-Oxidant Strategy or Antioxidant Approach?;Antioxidants;2022-08-29